{"id":20951,"date":"2015-08-19T18:35:39","date_gmt":"2015-08-19T16:35:39","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=20951"},"modified":"2015-08-19T18:42:21","modified_gmt":"2015-08-19T16:42:21","slug":"farmaceutica-lundbeck-annuncia-piano-ristrutturazione-e-taglio-di-mille-posti","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/farmaceutica-lundbeck-annuncia-piano-ristrutturazione-e-taglio-di-mille-posti\/","title":{"rendered":"Pharmaceuticals: Lundbeck announces restructuring plan and a thousand job cuts"},"content":{"rendered":"<p><a href=\"http:\/\/www.borsaitaliana.it\/borsa\/notizie\/radiocor\/finanza\/dettaglio\/nRC_19082015_1113_180341516.html\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft\" src=\"http:\/\/www.pharmafile.com\/system\/files\/imagecache\/news_full\/lundbeck_dark_1.jpg\" alt=\"\" width=\"281\" height=\"188\" \/>(Il Sole 24 Ore Radiocor)<\/a> \u2013 Rome, August 19 \u2013 The Danish pharmaceutical company Lundbeck has announced a substantial restructuring plan which will lead to the dismissal of about a thousand employees, of which 300 in Denmark. The plan aims to reduce costs by 3 billion crowns ($400 million) by 2017 and is expected to affect one in 6 employees mainly &quot;in headquarters and commercial operations in Europe and other markets,&quot; the company explained in a statement. Between April and June, Lundbeck recorded a net loss of SEK 3.9 billion while revenues for the quarter increased by 5% to SEK 3.63 billion. The new plan was well received by the Copenhagen Stock Exchange where the group&#039;s shares gained more than 11% in a downturn (-1.27%).<\/p>\n<p>Related news:\u00a0<a href=\"http:\/\/www.wsj.com\/articles\/drugmaker-h-lundbeck-to-cut-staff-costs-to-restore-profitability-1439994539\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">Drugmaker H. Lundbeck to Cut Staff, Costs to Restore Profitability<\/span><\/a><\/p>\n<p class=\"lede-headline\"><a href=\"http:\/\/www.bloomberg.com\/news\/articles\/2015-08-19\/lundbeck-cuts-17-of-jobs-as-new-ceo-fights-generic-competition\" target=\"_blank\" rel=\"noopener\"><span class=\"lede-headline__highlighted\" style=\"color: #0000ff;\">Lundbeck Surges as New CEO Cuts 1,000 Jobs to Fight Generics<\/span><\/a><\/p>\n<p><span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"http:\/\/www.fedaiisf.it\/en\/lundbeck-italia-rigoldi-%C2%93annunciati-104-esuberi-inaccettabili%C2%94\/\" target=\"_blank\">Lundbeck Italy, Rigoldi: 104 redundancies announced. Unacceptable<\/a><\/span> (2012)<\/p>\n<p><span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"http:\/\/www.fedaiisf.it\/en\/lundbeck-annuncia-600-esuberi-quasi-tutti-in-europa\/\" target=\"_blank\">LUNDBECK announces 600 redundancies, almost all in Europe<\/a><\/span> (2012)<\/p>","protected":false},"excerpt":{"rendered":"<p>(Il Sole 24 Ore Radiocor) &#8211; Roma, 19 ago &#8211; La societa&#8217; farmaceutica danese Lundbeck ha annunciato un consistente piano di ristrutturazione che portera&#8217; al licenziamento di circa mille dipendenti, di cui 300 in Danimarca. Il piano mira a ridurre i costi di 3 miliardi di corone (400 milioni di dollari) entro il 2017 e &hellip;<\/p>","protected":false},"author":4,"featured_media":20954,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[27],"class_list":["post-20951","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-licenziati"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/20951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=20951"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/20951\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/20954"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=20951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=20951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=20951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}